On September 28, 2023, Yunnan Jianzhijia Chongqing Qinkang Pharmaceutical Co., Ltd. closed the transaction. The company announced that it has completed the change registration procedures, and obtained a new "Business License". The registered capital of the company is CNY 80 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
50.8 CNY | -2.66% | -2.59% | -14.48% |
26/04 | Jianzhijia Pharmaceutical Chain Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
13/02 | JZJ Chain Drugstore Acquires 69 Pharmacies For 46 Million Yuan | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.48% | 93Cr | |
-31.33% | 1.13TCr | |
+13.51% | 646.65Cr | |
-30.66% | 632.21Cr | |
-8.33% | 608.5Cr | |
+74.00% | 494.97Cr | |
-1.61% | 467.23Cr | |
-6.00% | 394.93Cr | |
-16.14% | 334.33Cr | |
-12.02% | 292.49Cr |
- Stock Market
- Equities
- 605266 Stock
- News Jianzhijia Pharmaceutical Chain Group Co., Ltd.
- Yunnan Jianzhijia Chongqing Qinkang Pharmaceutical Co., Ltd. announced that it has received CNY 50 million in funding from Jianzhijia Pharmaceutical Chain Group Co., Ltd.